Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: Australia Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20062
20083
20091
20111
20131
20151
20174
20184
20191
20208
20213
20224
20238
202412
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting17
Active, not recruiting11
Terminated4
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Merck Sharp & Dohme LLC3
Queensland Centre for Gynaecological Cancer3
Agenus Inc.2
AstraZeneca2
Daiichi Sankyo2
GlaxoSmithKline2
MacroGenics2
OncoC4, Inc.2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms61
Ovarian Neoplasms27
Carcinoma, Non-Small-Cell Lung22
Squamous Cell Carcinoma of Head and Neck21
Endometrial Neoplasms20
Colorectal Neoplasms18
Triple Negative Breast Neoplasms18
Breast Neoplasms17
Melanoma15
Stomach Neoplasms15

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.